Probable role of Brain Natriuretic Peptide (BNP) in lung hypertension secondary to scleroderma

BACKGROUND Scleroderma, when complicated with pulmonary hypertension (PHT), presents a worse prognosis; recently treatment with new drugs seems to offer good perspectives, especially in early diagnosis and treatment. The standard approach for diagnosing PHT consists in measurement of the pulmonary a...

Full description

Bibliographic Details
Main Authors: P. Faggioli, S. Finazzi, E. Vicenzi, L. Giani, M. Rondena, M. Lotzniker, A. Mazzone
Format: Article
Language:English
Published: PAGEPress Publications 2013-05-01
Series:Italian Journal of Medicine
Subjects:
Online Access:http://www.italjmed.org/index.php/ijm/article/view/375
_version_ 1797431043637116928
author P. Faggioli
S. Finazzi
E. Vicenzi
L. Giani
M. Rondena
M. Lotzniker
A. Mazzone
author_facet P. Faggioli
S. Finazzi
E. Vicenzi
L. Giani
M. Rondena
M. Lotzniker
A. Mazzone
author_sort P. Faggioli
collection DOAJ
description BACKGROUND Scleroderma, when complicated with pulmonary hypertension (PHT), presents a worse prognosis; recently treatment with new drugs seems to offer good perspectives, especially in early diagnosis and treatment. The standard approach for diagnosing PHT consists in measurement of the pulmonary artery pressure (PAP) by means of echodoppler. <br />AIM OF INVESTIGATION Aim of this work is evaluating the significance of the NT-proBNP parameter, matched to echodoppler, in diagnosing scleroderma PHT. <br />MATERIALS AND METHODS Sixty (60) patients, who came to observation for progressive systemic sclerosis underwent echodoppler in order to measure the PAP (normal values up to 30 mmHg). NT-proBNP was determined on serum sample using ECLIA method by Modular E170 (Roche Diagnostics); manufacturer reference values for age and gender were used. Forty-three (43) patients underwent a further NT-proBNP sampling 5 days later in order to assess parameter stability. <br />RESULTS PHT and non- PHT patients showed statistically different (p &lt; 0,001) medians (126 vs 69 pg/ml). No pathologic values of NT-proBNP were measured in the group with PAP &lt; 30 mmHg, while 27% of cases who had PAP between 30 and 40 showed pathologic concentrations. The positivity ratio increases to 57% in patients showing PAP &gt; 40 mmHg. No relevant correlation (r = 0,2) was found between PAP and NT-proBNP. Mean average between the two sampling groups was 31%. <br />CONCLUSIONS In scleroderma patients, combination of NT-proBNP and PAP seems to improve the diagnosis of pulmonary hypertension, especially in presence of borderline pulmonary pressure values. We therefore propose the biochemical observation of NT-proBNP when PAP is &gt; 30 mmHg and in monitoring the evolution of the pathology.
first_indexed 2024-03-09T09:36:16Z
format Article
id doaj.art-e0617547f6af4d46b3830a0624648791
institution Directory Open Access Journal
issn 1877-9344
1877-9352
language English
last_indexed 2024-03-09T09:36:16Z
publishDate 2013-05-01
publisher PAGEPress Publications
record_format Article
series Italian Journal of Medicine
spelling doaj.art-e0617547f6af4d46b3830a06246487912023-12-02T02:02:13ZengPAGEPress PublicationsItalian Journal of Medicine1877-93441877-93522013-05-0111232510.4081/itjm.2007.1.23329Probable role of Brain Natriuretic Peptide (BNP) in lung hypertension secondary to sclerodermaP. FaggioliS. FinazziE. VicenziL. GianiM. RondenaM. LotznikerA. MazzoneBACKGROUND Scleroderma, when complicated with pulmonary hypertension (PHT), presents a worse prognosis; recently treatment with new drugs seems to offer good perspectives, especially in early diagnosis and treatment. The standard approach for diagnosing PHT consists in measurement of the pulmonary artery pressure (PAP) by means of echodoppler. <br />AIM OF INVESTIGATION Aim of this work is evaluating the significance of the NT-proBNP parameter, matched to echodoppler, in diagnosing scleroderma PHT. <br />MATERIALS AND METHODS Sixty (60) patients, who came to observation for progressive systemic sclerosis underwent echodoppler in order to measure the PAP (normal values up to 30 mmHg). NT-proBNP was determined on serum sample using ECLIA method by Modular E170 (Roche Diagnostics); manufacturer reference values for age and gender were used. Forty-three (43) patients underwent a further NT-proBNP sampling 5 days later in order to assess parameter stability. <br />RESULTS PHT and non- PHT patients showed statistically different (p &lt; 0,001) medians (126 vs 69 pg/ml). No pathologic values of NT-proBNP were measured in the group with PAP &lt; 30 mmHg, while 27% of cases who had PAP between 30 and 40 showed pathologic concentrations. The positivity ratio increases to 57% in patients showing PAP &gt; 40 mmHg. No relevant correlation (r = 0,2) was found between PAP and NT-proBNP. Mean average between the two sampling groups was 31%. <br />CONCLUSIONS In scleroderma patients, combination of NT-proBNP and PAP seems to improve the diagnosis of pulmonary hypertension, especially in presence of borderline pulmonary pressure values. We therefore propose the biochemical observation of NT-proBNP when PAP is &gt; 30 mmHg and in monitoring the evolution of the pathology.http://www.italjmed.org/index.php/ijm/article/view/375BNPLung hypertensionScleroderma.
spellingShingle P. Faggioli
S. Finazzi
E. Vicenzi
L. Giani
M. Rondena
M. Lotzniker
A. Mazzone
Probable role of Brain Natriuretic Peptide (BNP) in lung hypertension secondary to scleroderma
Italian Journal of Medicine
BNP
Lung hypertension
Scleroderma.
title Probable role of Brain Natriuretic Peptide (BNP) in lung hypertension secondary to scleroderma
title_full Probable role of Brain Natriuretic Peptide (BNP) in lung hypertension secondary to scleroderma
title_fullStr Probable role of Brain Natriuretic Peptide (BNP) in lung hypertension secondary to scleroderma
title_full_unstemmed Probable role of Brain Natriuretic Peptide (BNP) in lung hypertension secondary to scleroderma
title_short Probable role of Brain Natriuretic Peptide (BNP) in lung hypertension secondary to scleroderma
title_sort probable role of brain natriuretic peptide bnp in lung hypertension secondary to scleroderma
topic BNP
Lung hypertension
Scleroderma.
url http://www.italjmed.org/index.php/ijm/article/view/375
work_keys_str_mv AT pfaggioli probableroleofbrainnatriureticpeptidebnpinlunghypertensionsecondarytoscleroderma
AT sfinazzi probableroleofbrainnatriureticpeptidebnpinlunghypertensionsecondarytoscleroderma
AT evicenzi probableroleofbrainnatriureticpeptidebnpinlunghypertensionsecondarytoscleroderma
AT lgiani probableroleofbrainnatriureticpeptidebnpinlunghypertensionsecondarytoscleroderma
AT mrondena probableroleofbrainnatriureticpeptidebnpinlunghypertensionsecondarytoscleroderma
AT mlotzniker probableroleofbrainnatriureticpeptidebnpinlunghypertensionsecondarytoscleroderma
AT amazzone probableroleofbrainnatriureticpeptidebnpinlunghypertensionsecondarytoscleroderma